Comparative Analysis of Disease-Modifying Therapies for Multiple Sclerosis Ohikhuare Okun1*, Rapahel Udedike2, Ohene Poku Agyemang3, Promise Eromosele Ogbewele4, Omoikhoa Irele-Ifijeh5, Michael Iboyi6, Osahon Rex Igbinomwanhia7, Jatto Obehi Immaculate8 Abstract This review examines the role of disease-modifying therapies (DMTs) in treating multiple sclerosis, a chronic autoimmune disease affecting the central nervous